Literature DB >> 16446436

Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins.

Paul Dean1, Marc Maresca, Stephanie Schüller, Alan D Phillips, Brendan Kenny.   

Abstract

Enteropathogenic Escherichia coli (EPEC) induces a severe watery diarrhea responsible for several hundred thousand infant deaths each year by a process correlated with the loss (effacement) of absorptive microvilli. Effacement is linked to the locus of enterocyte effacement pathogenicity island that encodes an "injection system," "effector" proteins, and the Intimin outer membrane protein. Here, we reveal that effacement (i) is a two-step process, (ii) requires the cooperative action of three injected effectors (Map, EspF, and Tir) as well as Intimin, and (iii) leads to the retention, not release (into the extracellular milieu), of the detached microvillar material. We also discover that EPEC rapidly inactivates the sodium-d-glucose cotransporter (SGLT-1) by multiple mechanisms. Indeed, the finding that one mechanism occurs more rapidly than microvilli effacement provides a plausible explanation for the rapid onset of severe watery diarrhea, given the crucial role of SGLT-1 in the daily uptake of approximately 6 liters of fluids from the normal intestine. The importance of SGLT-1 in the disease process is supported by severe EPEC diarrheal cases being refractory to oral rehydration therapy (dependent on SGLT-1 function). Moreover, the identification of effector activities that alter microvilli structure and SGLT-1 function provides new tools for studying the underlying regulatory processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446436      PMCID: PMC1413648          DOI: 10.1073/pnas.0509451103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin.

Authors:  Toshio Kodama; Yukihiro Akeda; Gengo Kono; Akira Takahashi; Kinichi Imura; Tetsuya Iida; Takeshi Honda
Journal:  Cell Microbiol       Date:  2002-04       Impact factor: 3.715

2.  Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules.

Authors:  Brendan Kenny; Sarah Ellis; Alan D Leard; Jonathan Warawa; Harry Mellor; Mark A Jepson
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

3.  More than apical: Distribution of SGLT1 in Caco-2 cells.

Authors:  Helmut Kipp; Saeed Khoursandi; Daniel Scharlau; Rolf K H Kinne
Journal:  Am J Physiol Cell Physiol       Date:  2003-05-28       Impact factor: 4.249

Review 4.  Management of infectious diarrhoea.

Authors:  A C Casburn-Jones; M J G Farthing
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

5.  Enteropathogenic Escherichia coli (EPEC)-- a crafty subversive little bug.

Authors:  Brendan Kenny
Journal:  Microbiology       Date:  2002-07       Impact factor: 2.777

6.  Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells.

Authors:  Mark A Jepson; Stephanie Pellegrin; Leon Peto; David N Banbury; Alan D Leard; Harry Mellor; Brendan Kenny
Journal:  Cell Microbiol       Date:  2003-11       Impact factor: 3.715

7.  Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2.

Authors:  O Marchès; J P Nougayrède; S Boullier; J Mainil; G Charlier; I Raymond; P Pohl; M Boury; J De Rycke; A Milon; E Oswald
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition.

Authors:  Olivier Marchès; Terence Neil Ledger; Michèle Boury; Masaru Ohara; Xuanlin Tu; Frédéric Goffaux; Jacques Mainil; Ilan Rosenshine; Motoyuki Sugai; Jean De Rycke; Eric Oswald
Journal:  Mol Microbiol       Date:  2003-12       Impact factor: 3.501

9.  Effects of enteropathogenic Escherichia coli on microvillar membrane proteins during organ culture of rabbit intestinal mucosa.

Authors:  H Embaye; C A Hart; B Getty; J N Fletcher; J R Saunders; R M Batt
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

10.  Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice.

Authors:  Wanyin Deng; Bruce A Vallance; Yuling Li; Jose L Puente; B Brett Finlay
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

View more
  55 in total

Review 1.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

2.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

3.  Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.

Authors:  Anand Prakash Singh; Saima Aijaz
Journal:  Bioengineered       Date:  2015-10-02       Impact factor: 3.269

4.  EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Cell Microbiol       Date:  2017-07-27       Impact factor: 3.715

5.  The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.

Authors:  Kim Hodges; Neal M Alto; K Ramaswamy; Pradeep K Dudeja; Gail Hecht
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

8.  The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction.

Authors:  Paul Dean; Jon A Scott; Andrew A Knox; Sabine Quitard; Nicholas J Watkins; Brendan Kenny
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

9.  Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Authors:  Kirk S B Bergstrom; Vanessa Kissoon-Singh; Deanna L Gibson; Caixia Ma; Marinieve Montero; Ho Pan Sham; Natasha Ryz; Tina Huang; Anna Velcich; B Brett Finlay; Kris Chadee; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.